
Reset all filters
01 4Viberzi
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 157
2016 Revenue in Millions : 93
Growth (%) : 68
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 178
2017 Revenue in Millions : 157
Growth (%) : 13%
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2019 Revenue in Millions : 190
2018 Revenue in Millions : 178
Growth (%) : 7
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2016 Revenue in Millions : 93
2015 Revenue in Millions : 12
Growth (%) : 675